Basel T. Assaf

620 total citations
17 papers, 394 citations indexed

About

Basel T. Assaf is a scholar working on Molecular Biology, Epidemiology and Virology. According to data from OpenAlex, Basel T. Assaf has authored 17 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Epidemiology and 4 papers in Virology. Recurrent topics in Basel T. Assaf's work include Herpesvirus Infections and Treatments (5 papers), Cytomegalovirus and herpesvirus research (5 papers) and Virus-based gene therapy research (4 papers). Basel T. Assaf is often cited by papers focused on Herpesvirus Infections and Treatments (5 papers), Cytomegalovirus and herpesvirus research (5 papers) and Virus-based gene therapy research (4 papers). Basel T. Assaf collaborates with scholars based in United States and Israel. Basel T. Assaf's co-authors include Fernando Dangond, Samia J. Khoury, Jaime Imitola, Rajiv R. Ratan, Karen Smith, Daehee Hwang, Sandra Camelo, Hoon Ryu, Brett Langley and Robert J. Ferrante and has published in prestigious journals such as Journal of Virology, Human Reproduction and Journal of Neuroimmunology.

In The Last Decade

Basel T. Assaf

16 papers receiving 384 citations

Peers

Basel T. Assaf

IMMUN

EPIDE

GENET

CMN

Brenda Brankin United Kingdom

Julia Hornig United States

Sarah E. Hammond United States

Bryn Eagleson United States

Jenny Gu United States

Xueqing Lun Canada

Johannes Lampe Germany

Grace Athas United States

Paul Baum United States

Brenda Brankin United Kingdom

Basel T. Assaf

229 ×1.1

88 ×1.0

IMMUN

93 ×1.1

EPIDE

40 ×0.6

GENET

21 ×0.5

CMN

Citations per year, relative to Basel T. Assaf Basel T. Assaf (= 1×) peers Brenda Brankin

Countries citing papers authored by Basel T. Assaf

Since Specialization

Citations

This map shows the geographic impact of Basel T. Assaf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Basel T. Assaf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Basel T. Assaf more than expected).

Fields of papers citing papers by Basel T. Assaf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Basel T. Assaf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Basel T. Assaf. The network helps show where Basel T. Assaf may publish in the future.

Co-authorship network of co-authors of Basel T. Assaf

This figure shows the co-authorship network connecting the top 25 collaborators of Basel T. Assaf. A scholar is included among the top collaborators of Basel T. Assaf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Basel T. Assaf. Basel T. Assaf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Assaf, Basel T.. (2024). Systemic Toxicity of Recombinant Adeno-Associated Virus Gene Therapy Vectors. Toxicologic Pathology. 52(8). 523–530. 4 indexed citations

Bennet, Bindu, Ingrid D. Pardo, Basel T. Assaf, et al.. (2023). Scientific and Regulatory Policy Committee Technical Review: Biology and Pathology of Ganglia in Animal Species Used for Nonclinical Safety Testing. Toxicologic Pathology. 51(5). 278–305. 5 indexed citations

Bennet, Bindu, Ingrid D. Pardo, Basel T. Assaf, et al.. (2023). Scientific and Regulatory Policy Committee Points to Consider: Sampling, Processing, Evaluation, Interpretation, and Reporting of Test Article-Related Ganglion Pathology for Nonclinical Toxicity Studies. Toxicologic Pathology. 51(4). 176–204. 7 indexed citations

Hutt, Julie A., Basel T. Assaf, Brad Bolon, et al.. (2021). Scientific and Regulatory Policy Committee Points to Consider: Nonclinical Research and Development of In Vivo Gene Therapy Products, Emphasizing Adeno-Associated Virus Vectors. Toxicologic Pathology. 50(1). 118–146. 16 indexed citations

Gil, M. M., Yaakov Bentov, Basel T. Assaf, et al.. (2021). O-225 Effects of SARS-Corona virus 2 on IVF treatment parameters: A cohort study of post COVID-19 patients. Human Reproduction. 36(Supplement_1). 1 indexed citations

Assaf, Basel T. & Laurence O. Whiteley. (2018). Considerations for Preclinical Safety Assessment of Adeno-Associated Virus Gene Therapy Products. Toxicologic Pathology. 46(8). 1020–1027. 20 indexed citations

Owston, Michael, et al.. (2017). Cytomegaloviral hypophysitis in a simian immunodeficiency virus‐infected rhesus macaque (Macacca mulatta). Journal of Medical Primatology. 46(6). 364–367.

Assaf, Basel T., Heather Knight, & Andrew D. Miller. (2014). Rhesus Cytomegalovirus (Macacine Herpesvirus 3)–Associated Facial Neuritis in Simian Immunodeficiency Virus–Infected Rhesus Macaques (Macaca mulatta). Veterinary Pathology. 52(1). 217–223. 5 indexed citations

Assaf, Basel T., et al.. (2014). Preclinical Study Design for Evaluation of Stem Cell–derived Cellular Therapy Products. Toxicologic Pathology. 43(1). 126–131. 1 indexed citations

10.

Assaf, Basel T., Keith G. Mansfield, Lisa Strelow, et al.. (2014). Limited Dissemination and Shedding of the UL128 Complex-Intact, UL/b′-Defective Rhesus Cytomegalovirus Strain 180.92. Journal of Virology. 88(16). 9310–9320. 12 indexed citations

11.

Basu, Joydeep, Basel T. Assaf, Timothy A. Bertram, & Mahendra S. Rao. (2014). Preclinical Biosafety Evaluation of Cell-based Therapies. Toxicologic Pathology. 43(1). 115–125. 10 indexed citations

12.

Assaf, Basel T., Keith G. Mansfield, Susan V. Westmoreland, et al.. (2012). Patterns of Acute Rhesus Cytomegalovirus (RhCMV) Infection Predict Long-Term RhCMV Infection. Journal of Virology. 86(11). 6354–6357. 13 indexed citations

13.

Genescà, Meritxell, Zhong-Min Ma, Yichuan Wang, et al.. (2012). Live-Attenuated Lentivirus Immunization Modulates Innate Immunity and Inflammation while Protecting Rhesus Macaques from Vaginal Simian Immunodeficiency Virus Challenge. Journal of Virology. 86(17). 9188–9200. 13 indexed citations

14.

Westmoreland, Susan V., Lakshmanan Annamalai, Margaret R. Lentz, et al.. (2011). Growth-associated protein-43 and ephrin B3 induction in the brain of adult SIV-infected rhesus macaques. Journal of NeuroVirology. 17(5). 455–468. 2 indexed citations

15.

Assaf, Basel T. & Andrew D. Miller. (2011). Pleural Endometriosis in an Aged Rhesus Macaque (Macaca mulatta). Veterinary Pathology. 49(4). 636–641. 14 indexed citations

16.

Abel, Kristina, Joy Martinez, Yujuan Yue, et al.. (2010). Vaccine-Induced Control of Viral Shedding following Rhesus Cytomegalovirus Challenge in Rhesus Macaques. Journal of Virology. 85(6). 2878–2890. 41 indexed citations

17.

Camelo, Sandra, Antonio Iglesias, Daehee Hwang, et al.. (2005). Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 164(1-2). 10–21. 230 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact